On specialist advice
MHRA Advice When prescribing for epilepsy, the potential for clinically relevant differences to exist between different manufacturers' product is considered to be extremely low. However, consider otherpatient / carer related factors, such as negative perceptions about alternative products and/or other issues related to the patient such co-morbid autism, mental health issues, or learning disability |